Page 120 - OR-1-2

lymphocytes using tumor organoid co-cultures. Cancer 2021;66:103303.
Immunol Immunother. 2024;73:164.
doi: 10.1016/j.ebiom.2021.103303
doi: 10.1007/s00262-024-03749-8
87. Liu X, Fang J, Huang S, et al. Tumor-on-a-chip: From
84. Cauli E, Polidoro MA, Marzorati S, Bernardi C, Rasponi M, bioinspired design to biomedical application. Microsyst
Lleo A. Cancer-on-chip: A 3D model for the study of the Nanoeng. 2021;7(1):1-23.
tumor microenvironment. J Biol Eng. 2023;17:53. doi: 10.1038/s41378-021-00277-8
doi: 10.1186/s13036-023-00372-6 88. Shirure VS, Bi V, Curtis MB, et al. Tumor-on-a-chip
85. Jouybar M, De Winde CM, Wolf V, Friedl P, Mebius RE, platform to investigate progression and drug sensitivity in
Den Toonder JMA. Cancer-on-chip models for metastasis: cell lines and patient-derived organoids. Lab Chip. 2018;18:
Importance of the tumor microenvironment. Trends 3687-3702.
Biotechnol. 2024;42:431-448. doi: 10.1039/c8lc00596f
doi: 10.1016/j.tibtech.2023.10.001 89. Gunti S, Hoke ATK, Vu KP, London NR. Organoid and
86. Komen V, Van Neerven SM, Van den Berg V, Vermeulen V, spheroid tumor models: Techniques and applications.
Van der Meer AD. Mimicking and surpassing the xenograft Cancers. 2021;13:874.
model with cancer-on-chip technology. EBioMedicine. doi: 10.3390/cancers13040874

Volume 1 Issue 2 (2025) 14 doi: 10.36922/OR025050008